Will you have Metastases to bone with Paxil - from FDA reports

Summary

Metastases to bone is found among people who take Paxil, especially for people who are female, 60+ old also take medication Zometa, and have Breast cancer metastatic. This study is created by eHealthMe based on reports of 81,621 people who have side effects when taking Paxil from FDA, and is updated regularly.



What's eHealthMe?

eHealthMe is a health data analysis company based in Mountain View, California. eHealthMe monitors and analyzes the outcomes of drugs and supplements that are currently on the market. The results are readily available to health care professionals and consumers.

eHealthMe has released original studies on market drugs and worked with leading universities and institutions such as IBM, London Health Science Centre, Mayo Clinic, Northwestern University and VA. eHealthMe studies have now been referenced in over 500 peer-reviewed medical publications.

How we gather our data?

Healthcare data is obtained from a number of sources including the Food and Drug Administration (FDA). This information is aggregated and used to produce personalized reports that patients can reference.

The information that eHealthMe collects includes:

  • Side effects (including severity and how people recover from them)
  • Associated conditions or symptoms
  • Drug effectiveness
  • Demographic data regarding drug use

How the study uses the data?

The study is based on paroxetine hydrochloride (the active ingredients of Paxil) and Paxil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Synonyms of Metastases to bone are also considered in the study.

What is Paxil?

Paxil has active ingredients of paroxetine hydrochloride. It is often used in depression. (latest outcomes from Paxil 84,999 users)

What is Metastases to bone?

Metastases to bone (cancer spreads to bone) has been reported by people with breast cancer, metastases to bone, breast cancer metastatic, prostate cancer, pain (latest reports from 32,933 Metastases to bone patients).

How to use the study?

Patients can bring a copy of the report to their healthcare provider to ensure that all drug risks and benefits are fully discussed and understood. It is recommended that patients use the information presented as a part of a broader decision-making process.


On Mar, 11, 2019

81,621 people reported to have side effects when taking Paxil.
Among them, 350 people (0.43%) have Metastases to bone


Number of reports submitted per year:

Could Paxil cause Metastases to bone?

Gender of people who have Metastases to bone when taking Paxil *:

  • female: 81.71 %
  • male: 18.29 %

Age of people who have Metastases to bone when taking Paxil *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.39 %
  • 20-29: 2.71 %
  • 30-39: 6.98 %
  • 40-49: 21.32 %
  • 50-59: 33.72 %
  • 60+: 34.88 %

Top conditions involved for these people *:

  1. Breast Cancer Metastatic: 101 people, 28.86%
  2. Neoplasm Malignant (cancer tumour): 55 people, 15.71%
  3. Breast Cancer: 49 people, 14.00%
  4. Pain: 26 people, 7.43%
  5. Muscle Spasms (muscle contraction): 20 people, 5.71%
  6. Osteoporosis (bones weak and more likely to break): 18 people, 5.14%
  7. Constipation: 17 people, 4.86%
  8. Prostate Cancer: 16 people, 4.57%
  9. Bone Loss: 16 people, 4.57%
  10. Sleep Disorder: 15 people, 4.29%

Top co-used drugs for these people *:

  1. Zometa: 294 people, 84.00%
  2. Aredia: 162 people, 46.29%
  3. Ambien: 134 people, 38.29%
  4. Femara: 115 people, 32.86%
  5. Aromasin: 101 people, 28.86%
  6. Tamoxifen Citrate: 98 people, 28.00%
  7. Prednisone: 97 people, 27.71%
  8. Taxotere: 95 people, 27.14%
  9. Decadron: 94 people, 26.86%
  10. Aspirin: 94 people, 26.86%

Top other side effects for these people *:

  1. Pain: 298 people, 85.14%
  2. Osteonecrosis Of Jaw (death of bone of jaw): 270 people, 77.14%
  3. Bone Disorder: 215 people, 61.43%
  4. Osteomyelitis (infection of bone): 181 people, 51.71%
  5. Back Pain: 174 people, 49.71%
  6. Anaemia (lack of blood): 168 people, 48.00%
  7. Breathing Difficulty: 168 people, 48.00%
  8. Osteoarthritis (a joint disease caused by cartilage loss in a joint): 152 people, 43.43%
  9. Injury: 145 people, 41.43%
  10. Fatigue (feeling of tiredness): 144 people, 41.14%

* Approximation only. Some reports may have incomplete information.


Do you have Metastases to bone while taking Paxil?

You are not alone:




Related publications that referenced our studies

Related studies

Drugs that are associated with Metastases to bone
Metastases to bone (1,443 drugs)
Could your condition cause Metastases to bone
Metastases to bone (755 conditions)
Paxil side effects

Browse side effects by gender and age

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+


Browse all side effects of Paxil
a b c d e f g h i j k l m n o p q r s t u v w x y z
Compare Paxil with similar drugs


What would happen?

Predict new side effects and undetected conditions when you take Paxil and have Metastases to bone



FDA reports used in this study


Recent updates

Recent general studies
Recent personal studies


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.